Skip to Content
 
Center for International Blood and Marrow Transplant Research

GV25-01

Main Content

Abatacept versus post-transplantation cyclophosphamide as GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation for myeloid malignancies.

Study #: GV25-01

Study Status: Protocol Development